Science Explorer Back to mapMap
Discussion
Company · Mississauga · Canada

Therapure Biopharma (Canada)

therapurebio.comROR OpenAlex
Research works
65
▼ 92% vs 2018-21
Citations
2.3k
35.5 per fractional work
Top-10% rate
3.2%
all institutions 10.0%
Open access
24%
world 40%
International
19%
world 18%
Therapure Biopharma (Canada)

Not ranked overall: Therapure Biopharma (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Therapure Biopharma (Canada) work in?

In all years, 68% of research at Therapure Biopharma (Canada) is in Life Sciences, 21% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (51%), Medicine (19%), Neuroscience (10%). It does 3.7× the world's share of Life Sciences.

Life Sciences: 44 fractional works · 68.3% of its workBiochemistry, Genetics and Molecular Biology: 33 fractional works · 50.6% of its workMolecular Biology: 27 fractional works · 42.0% of its workBiotechnology: 2 fractional works · 2.8% of its workGenetics: 2 fractional works · 2.3% of its workCell Biology: 1 fractional works · 1.7% of its workCancer Research: 1 fractional works · 1.3% of its workPhysiology: 0 fractional works · 0.5% of its workNeuroscience: 7 fractional works · 10.2% of its workCellular and Molecular Neuroscience: 5 fractional works · 7.6% of its workNeurology: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 4.8% of its workImmunology: 3 fractional works · 4.0% of its workVirology: 1 fractional works · 0.9% of its workAgricultural and Biological Sciences: 1 fractional works · 1.4% of its workPlant Science: 1 fractional works · 1.0% of its workFood Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.4% of its workPharmacology: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 14 fractional works · 21.0% of its workMedicine: 12 fractional works · 19.3% of its workOncology: 2 fractional works · 3.2% of its workPhysiology: 2 fractional works · 2.7% of its workEpidemiology: 1 fractional works · 1.8% of its workPsychiatry and Mental health: 1 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 1.1% of its workInfectious Diseases: 1 fractional works · 0.9% of its workHematology: 0 fractional works · 0.8% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.8% of its workNutrition and Dietetics: 0 fractional works · 0.8% of its workHealth Professions: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 10.2% of its workChemistry: 2 fractional works · 2.8% of its workSpectroscopy: 1 fractional works · 1.7% of its workOrganic Chemistry: 1 fractional works · 1.2% of its workMaterials Science: 1 fractional works · 2.2% of its workMaterials Chemistry: 1 fractional works · 1.7% of its workBiomaterials: 0 fractional works · 0.5% of its workEngineering: 1 fractional works · 2.1% of its workBiomedical Engineering: 1 fractional works · 1.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.4% of its workEcology: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 0.9% of its workComputational Theory and Mathematics: 1 fractional works · 0.9% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKTherapureBiopharma…65fractional works, all years
Life Sciences68%Physical Sciences10%Health Sciences21%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3350.6%
    2. Neuroscience710.2%
    3. Immunology and Microbiology34.8%
    4. Agricultural and Biological Sciences11.4%
    5. Pharmacology, Toxicology and Pharmaceutics11.4%
    1. Medicine1219.3%
    2. Nursing00.8%
    3. Health Professions00.5%
    4. Veterinary00.3%
    5. Dentistry00.2%
    1. Chemistry22.8%
    2. Materials Science12.2%
    3. Engineering12.1%
    4. Environmental Science11.4%
    5. Computer Science10.9%
    6. Energy00.5%
    7. Physics and Astronomy00.3%
    1. Economics, Econometrics and Finance00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Therapure Biopharma (Canada) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 10.6× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 27.2 works11×
  2. Biochemistry, Genetics and Molecular BiologyField · 32.7 works7.3×
  3. Life SciencesDomain · 44.1 works4.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Therapure Biopharma (Canada)?

Ranked on the quality score, David I. Gwynne, Martin Sumner-Smith and Lorne S. Reid lead among researchers whose main affiliation is Therapure Biopharma (Canada).

  1. 1 David I. Gwynne Canada · #981,766 worldwide 2k citations · 34 works
  2. 2 Martin Sumner-Smith Canada · #1,430,821 worldwide 1.6k citations · 27 works
  3. 3 Lorne S. Reid Canada · #1,721,371 worldwide 863 citations · 20 works
  4. 4 Ken H. Hoo Canada · #2,312,361 worldwide 1.2k citations · 17 works
  5. 5 Rajender Kumar Kamboj Canada · #3,323,064 worldwide 2k citations · 52 works
  6. 6 Robert L. Foldes Canada · #4,454,700 worldwide 344 citations · 22 works
All ranked researchers at Therapure Biopharma (Canada)

What are the most cited papers from Therapure Biopharma (Canada)?

The most cited paper from Therapure Biopharma (Canada) is "A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission" (Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al., 1997), with 416 citations. Next come "Kainate receptors are involved in synaptic plasticity" (324) and "Lysophospholipids activate ovarian and breast cancer cells" (285).

Most cited papers
#PaperReleasedCitations
1 A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al. · Nature Oct 1997 416
2 Kainate receptors are involved in synaptic plasticity Zuner Assis Bortolotto, Vernon R. J. Clarke, Caroline M. Delany et al. · Nature Open access 18 Nov 1999 324
3 Lysophospholipids activate ovarian and breast cancer cells Yan Juan Xu, X J Fang, Graham Casey et al. · Biochemical Journal Open access Aug 1995 285
4 Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV Daniel J. Drucker, Qing Wen Shi, Anna Crivici et al. · Nature Biotechnology Jul 1997 280
5 Calcium‐permeable α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis Timothy L. Williams, Niki C. Day, Paul G. Ince et al. · Annals of Neurology Aug 1997 216
All 60 most cited papers, with filters and sorting

Which keywords describe research at Therapure Biopharma (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Neurological Disorders, Drug Discovery, Cell Signaling, Synaptic Plasticity, GABAergic, Neurotransmission, Signal Transduction and Pharmacology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Neurological Disorders6▲ 15×4 topics
  2. Drug Discovery5▲ 19×2 topics
  3. Cell Signaling5▲ 21×4 topics
  4. Synaptic Plasticity4▲ 23×2 topics
  5. GABAergic4▲ 51×1 topic
  6. Neurotransmission4▲ 51×1 topic
  7. Signal Transduction4▲ 28×3 topics
  8. Cancer4▲ 4.6×12 topics
  9. Pharmacology4▲ 16×5 topics
  10. Crystal Structure3▲ 20×2 topics
  11. Gene Expression3▲ 7.9×6 topics
  12. Ribosome3▲ 47×1 topic
  13. Translation3▲ 23×1 topic
  14. Ion Channels3▲ 20×2 topics
  15. Protein-Protein Interactions3▲ 39×2 topics
  16. Arrestin3▲ 51×1 topic
  17. G-Protein-Coupled Receptors3▲ 51×1 topic
  18. Membrane Proteins3▲ 22×3 topics
  19. Innate Immunity2▲ 11×3 topics
  20. Foldamers2▲ 45×1 topic
  21. Gene Regulation2▲ 24×2 topics
  22. Peptide Synthesis2▲ 45×1 topic
  23. Angiogenesis2▲ 8.0×5 topics
  24. Immune Response2▲ 5.2×6 topics
  25. Apoptosis2▲ 7.9×5 topics
  26. Genomics2▲ 8.3×2 topics
  27. Cancer Therapy2▲ 4.5×5 topics
  28. Therapeutic Targets2▲ 12×2 topics
  29. Tumor Microenvironment2▲ 8.0×6 topics
  30. ADAR Deaminases2▲ 102×1 topic
  31. Glycosylation2▲ 12×2 topics
  32. Immune System2▲ 8.1×3 topics
  33. RNA Editing2▲ 102×1 topic
  34. Antiretroviral Therapy2▲ 10×3 topics
  35. Calcium Channels2▲ 33×1 topic
  36. Voltage-Gated Channels2▲ 33×1 topic
  37. DNA Structure1▲ 35×1 topic
  38. G-Quadruplexes1▲ 35×1 topic
  39. Glycans1▲ 25×1 topic
  40. Mucins1▲ 25×1 topic

Which research topics does Therapure Biopharma (Canada) publish most on?

By volume in 2022-now: Neuroendocrine Tumor Research Advances, Thyroid Cancer Diagnosis and Treatment, Lung Cancer Research Studies and Cancer Immunotherapy and Biomarkers.

Neuroendocrine Tumor Res…0Neuroendocrine Tumor Research Advances: 0 fractional worksThyroid Cancer Diagnosis…0Thyroid Cancer Diagnosis and Treatment: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional works
EpidemiologyEndocrinology, Diabetes and MetabolismOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  2. 2 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Lung Cancer Research Studies Oncology 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  6. 6 Chronic Kidney Disease and Diabetes Nephrology 0 works
  7. 7 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.7%not open76.3%

World: 40% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 18% is written across borders.

How has Therapure Biopharma (Canada)'s research output changed?

Output in 2022-2025 was 92% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Therapure Biopharma (Canada) as a percentage of every work published that year, 0.000019% in 2020.

still counting0.00050%0.0010%0.0015%Therapure Biopharma (Canada)0.0000012% in 20251990200020102020

Fractional works of Therapure Biopharma (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Therapure Biopharma (Canada). Posts are plain text and can be reported.